Trial intelligence / Profile preview

DOACs versus VKAs for patients undergoing balloon pulmonary angioplasty

NL-OMON53991Phase 4Recruiting

Sponsor
St. Antonius Ziekenhuis
Start
Mar 2021
Countries
1
01

Overview

Phase 4, open-label trial in chronic thromboembolic pulmonary hypertension (CTEPH) and chronic thromboembolic pulmonary disease (CTED) (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Primary composite endpoint. Started Mar 2021; status: recruiting.

02

Conditions

chronic thromboembolic pulmonary hypertension (CTEPH)chronic thromboembolic pulmonary disease (CTED)

Beyond the preview

Go deeper on NL-OMON53991.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON53991.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call